Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.
Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022.
CITIUS NEWS ARCHIVE
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.
Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant
PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...
The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...
The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21.
Revive Therapeutics (RVTTF), RedHill BioPharma...
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....
Dalrada (DFCO) Finally Pops. Up 59% Today.
Up 59% today on news and with 4 million shares trading and counting!
LIVE QUOTE
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.
New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks
GeoVax Live Webcast
Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and...
Adding GBT Technologies (GTCH) to the Watch List.
Massive Potential From California Based Technology Think Tank.
Yes, risky - as in...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
